To study the effect of unani drugs in patients with ringworm.
Phase 3
- Conditions
- Health Condition 1: B356- Tinea cruris
- Registration Number
- CTRI/2023/12/060636
- Lead Sponsor
- PG Department of Moalijat
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age between 12 months - 80 years
Both sexes
Clinically diagnosed patients of qooba (times cruris)
Patients who have signed the informed consent form
Exclusion Criteria
Patients suffering from concomitant diseases like psoriasis, eczema
Patients suffering from infection diseases
Patients suffering from severe systemic and metabolic diseases
Diabetic and hypertensive patients
STD diseases diagnosed patients
Pregnant and lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Relief in symptoms like itching, redness, burning and plaques.Timepoint: Symptoms will be assessed on 1st week, 2nd week, 3rd week, 4th week, 5th week and 6th week.
- Secondary Outcome Measures
Name Time Method To control recurrent infectionTimepoint: Recurrence will be optimised every month until 3 months